Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2011 Q1- Text added to 2011 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
announced, astrocytoma, bevacizumab, bone, bridging, carcinoma, choice, confidence, escalation, Francisco, gastrointestinal, glioblastoma, high, interval, July, master, neuroendocrine, nonowner, reclassified, recurrent, renal, San, serve, South, stromal, sunitinib, Sutent, unchanged, unresectable, untreated
Removed:
assuming, decline, director, disordered, internally, partially, transition, vessel
Valuein 2011 Q1 filing- Value in 2011 Q2 filing
Original filings
Filing view